Correo Electrónico
DNINFOA - SIA
Bibliotecas
Convocatorias
Identidad U.N.
Publicado
Predictores de potenciales reacciones adversas e interacciones medicamentosas en pacientes post accidente cerebrovascular en Perú
Predictors of potential adverse reactions and drug-drug interactions in post-stroke patients in Peru
DOI:
https://doi.org/10.15446/rsap.v24n4.100261Palabras clave:
Predictor, severidad, reacciones adversas medicamentosas, interacciones medicamentosas, accidente cerebrovascular (es)Predictor, severity, adverse drug reactions, drug-drug interactions, stroke (en)
Descargas
Objetivo Identificar los predictores clínicos y farmacoterapéuticos asociados a los niveles de severidad de las reacciones adversas (RAM) e interacciones medicamentosas (IM) en pacientes hospitalizados post accidente cerebrovascular.
Métodos Estudio analítico, predictivo y transversal mediante el modelo de regresión lineal múltiple. Los niveles de severidad de las potenciales reacciones adversas e interacciones medicamentosas se evaluaron mediante Drugs.com.
Resultados De la evaluación de 992 prescripciones médicas de 55 (56,7%) pacientes mujeres y 42 (43,3%) varones post accidente cerebrovascular isquémico 62 (63,9%) y hemorrágico 35 (36,1%), se identificó un total de 11790 ± 46,8 potenciales reacciones adversas y 1034 ± 9,8 interacciones medicamentosas. La hipertensión arterial se asoció a las reacciones adversas graves y moderadas, en tanto que la neumonía intrahospitalaria y alcalosis metabólica a reacciones adversas leves y moderadas. La alcalosis metabólica se asoció a las interacciones medicamentosas moderadas y leves. Los predictores farmacoterapéuticos como la prescripción en polifarmacia y el uso de antibióticos se relacionaron con reacciones adversas graves, moderadas y leves; los antidiabéticos se relacionaron con interacciones medicamentosas graves, moderadas y los fármacos para terapia cardiaca con interacciones medicamentosas leves.
Conclusiones Las variables clínicas como factores de riesgo cardiovascular, presencia de comorbilidades que exacerban las enfermedades crónicas no trasmisibles, los signos y síntomas de alarma, el mayor tiempo de estancia hospitalaria y la prescripción en polifarmacia fueron predictores de mayor frecuencia de reacciones adversas einteracciones medicamentosas graves y moderadas que requieren especial vigilancia y estudio individualizado.
Objective To identify clinical and pharmacotherapeutic predictors associated with severity levels of adverse reactions and drug-drug interactions in post-stroke hospita- lized patients.
Methods Analytic, predictive, cross-sectional study using multiple linear regression modeling. Severity levels of potential adverse reactions and drug-drug interactions were assessed using Drugs.com.
Results From the evaluation of 992 medical prescriptions of 55 (56.7%) female and 42 (43.3%) male patients post ischemic stroke 62 (63.9%) and hemorrhagic stroke 35 (36.1%); a total of 11790 ± 46.8 potential adverse reactions and 1034 ± 9.8 drug-drug interactions were identified; arterial hypertension was associated with severe and moderate adverse reactions; while in-hospital pneumonia and metabolic alkalosis with mild and moderate adverse reactions. While metabolic alkalosis was associated with moderate and mild drug-drug interactions. Pharmacotherapeutic predictors such as polypharmacy prescription and antibiotic use were related to moderate and mild severe adverse reactions; antidiabetic drugs were related to moderate and severe drug-drug interactions and cardiac therapy drugs were related to mild drug-drug interactions.
Conclusions Clinical variables such as cardiovascular risk factors, presence of comorbidities that exacerbate chronic noncommunicable diseases, alarm signs and symptoms, longer hospital stay, as well as polypharmacy prescriptions, were predictors of a higher frequency of severe and moderate adverse reactions and drug-drug interactions, which require special vigilance and individualized study.
Referencias
Organización Mundial de la Salud (OMS). Formulario Modelo de la OMS 2004. Consejo general a los prescriptores: Efectos adversos e interacciones [Internet]. Suiza; 2004 [citado 25 de Dic de 2021]. Disponible en: https://bit.ly/3EmxcsM.
Magro L, Arzenton E, Leone R, Stano MG, Vezzaro M, Rudolph A, et al. Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database. Front Pharmacol. 2020; 11:622862. https://doi.org/10.3389/fphar.2020.622862. DOI: https://doi.org/10.3389/fphar.2020.622862
Petrovic M, Tangiisuran B, Rajkumar C, Van der Cammen T, Onder G. Predicting the Risk of Adverse Drug Reactions in Older Inpatients: External Validation of the GerontoNet ADR Risk Score Using the CRIME Cohort. Drugs Aging. 2017; 34(2):135-142. https://doi.org/10.1007/s40266-016-0428-4. DOI: https://doi.org/10.1007/s40266-016-0428-4
Angamo MT, Curtain CM, Chalmers L, Yilma D, Bereznicki L. Predictors of Adverse Drug Reaction-Related Hospitalisation in Southwest Ethiopia: A prospective cross-sectional study. PLoS One. 2017; 12(10):e0186631. https://doi.org/10.1371/journal.pone.0186631. DOI: https://doi.org/10.1371/journal.pone.0186631
Girona L. Introducción a las interacciones medicamentosas [Internet]. España: Sociedad Española de Farmacia Hospitalaria (SEFH); 2013 [citado 20 de Dic de 2021]. Disponible en: https://bit.ly/3HdhAcM.
Létinier L, Ferreira A, Marceron A, Babin M, Micallef J, Miremont-Sala- mé G, et al. Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug-Drug Interactions: An Analysis From the French Pharmacovigilance Database. Front Pharmacol. 2020; 11:624562. https://doi.org/10.3389/fphar.2020.624562. DOI: https://doi.org/10.3389/fphar.2020.624562
Montané E, Santesmases J. Adverse Drug Reactions. Med Clin (Barc). 2020; 154(5):178-184. https://doi.org/10.1016/j.medcli.2019.08.007. DOI: https://doi.org/10.1016/j.medcle.2019.08.005
Gobezie MY, Bitew HB, Tuha A, Hailu HG. Assessment of Potential Drug-Drug Interactions and Their Predictors in Chronic Outpatient Department of Dessie Referral Hospital, Dessie, Northeast Ethiopia. Drug Healthc Patient Saf. 2021; 13:29-35. https://doi.org/10.2147/dhps.s279371. DOI: https://doi.org/10.2147/DHPS.S279371
Nusair MB, Al-Azzam SI, Arabyat RM, Amawi HA, Alzoubi KH, Rabah AA. The Prevalence and Severity of Potential Drug-Drug Interactions Among Adult Polypharmacy Patients at Outpatient Clinics in Jordan. Saudi Pharm J. 2020; 28(2):155-160. https://doi.org/10.1016/j.jsps.2019.11.009. DOI: https://doi.org/10.1016/j.jsps.2019.11.009
Schurig AM, Böhme M, Just KS, Scholl C, Dormann H, Plank-Kiegele B, et al. Adverse Drug Reactions (ADR) and Emergencies. Dtsch Arztebl Int. 2018; 115(15):251-258. https://dx.doi.org/10.3238/arztebl.2018.0251. DOI: https://doi.org/10.3238/arztebl.2018.0251
Koch L, Kränke B, Aberer W. Potential Drug-Drug Interactions and Adverse Drug Reactions in Dermatological Inpatients. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2016; 14(11):1122-1129. https://doi.org/10.1111/ddg.12915. DOI: https://doi.org/10.1111/ddg.12915
National Institute of Neurological Disorders and Stroke (NINDS). Accidente cerebrovascular: Esperanza en la investigación [Internet]. Estados Unidos: National Institute of Neurological Disorders and Stroke (NINDS); 2017 [citado 12 de diciembre de 2021]. Disponible en: https://bit.ly/3EsnQvu.
Díez-Tejedor E, Del Bruto O, Álvarez-Sabín J, Muñoz M, Abiusi G. Clasificación de las enfermedades cerebrovasculares. Sociedad Iberoamericana de Enfermedades Cerebrovasculares. REV NEUROL. 2001; 33(5):455-464. https://doi.org/10.33588/rn.3305.2001246. DOI: https://doi.org/10.33588/rn.3305.2001246
WHO Collaborating centre for drug statistics methodology (WHOCC). Guidelines for ATC classification and DDD assignment. [Internet]. Noruega: Norwegian Institute of Public Health; 2018 [citado 20 de Dic 2021]. Disponible en: https://bit.ly/3FJfFwx.
Asociación Médica Mundial. Declaración de Helsinki: Principios éticos para la investigación médica sobre sujetos humanos [Internet]. Escocia: Asociación Médica Mundial; 2000 [citado 12 de noviembre de 2021]. Disponible en: https://bit.ly/3Jbmn0a.
Centro Nacional de Información - Cuba. Accidente cerebrovascular. Diagnóstico, terapia y factores de riesgo. [Internet]. Cuba: Biblioteca Médica Nacional; 2017 [citado 21 de diciembre de 2021]. Disponible en: t.ly/0yOE.
Adoukonou T, Agbétou M, Bangbotché R, Kossi O, Fotso Mefo P, Magne J, et al. Long-Term Mortality of Stroke Survivors in Parakou: 5-Year Follow-Up. Journal of Stroke and Cerebrovascular Diseases. 2020; 29(6): 104785. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104785. DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104785
Hernández M, Tribiño G, Bustamante C. Caracterización de las potenciales interacciones farmacológicas en pacientes de una unidad de cuidados intensivos en un hospital de tercer nivel de Bogotá. Revista Biomédica. 2018; 38(3):407-416. https://doi.org/10.7705/biomedica.v38i4.3884. DOI: https://doi.org/10.7705/biomedica.v38i4.3884
Caribé RA, Chaves GR. Potenciales interacciones medicamentosas en pacientes con sepsis internados en la unidad de terapia intensiva. Farmacia Hospitalaria. 2013; 37(5):383-387. http://dx.doi.org/10.7399/FH.2013.37.5.534.
Ismail M, Noor S, Harram U, Haq I, Haider I, Khadim F, et al. Potential Drug-Drug Interactions in Outpatient Department of a Tertiary Care Hospital in Pakistan: A Cross-Sectional Study. BMC Health Serv Res. 2018; 18(1):762. https://doi.org/10.1186/s12913-018-3579-7. DOI: https://doi.org/10.1186/s12913-018-3579-7
Leelakanok N, Holcombe AL, Lund BC, Gu X, Schweizer ML. Association between polypharmacy and death: A systematic review and meta-analysis. J Am Pharm Assoc. 2017; 57(6):729-738. http://dx.doi.org/10.1016/j.japh.2017.06.002. DOI: https://doi.org/10.1016/j.japh.2017.06.002
Bhagavathula AS, Vidyasagar K, Chhabra M, Rashid M, Sharma R, Bandari DK, et al. Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis. Front Pharmacol. 2021; 12:685518. https://doi.org/10.3389/fphar.2021.685518. DOI: https://doi.org/10.3389/fphar.2021.685518
Bhatt AN, Paul SS, Krishnamoorthy S, Baby BT, Mathew A, Nair BR. Potentially Inappropriate Medications Prescribed for Older Persons: A Study From Two Teaching Hospitals in Southern India. J Family Com- munity Med. 2019; 26(3):187-192. https://doi.org/10.4103/jfcm.JFCM_81_19.
Cómo citar
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Descargar cita
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Esta revista provee acceso libre inmediato a su contenido bajo el principio de que hacer disponible gratuitamente investigación al publico apoya a un mayor intercambio de conocimiento global.
Todos los contenidos de esta revista, excepto dónde está identificado, están publicados bajo una Licencia Creative Commons Atribución 4.0.
